Sponsor:
Jeffrey N. Bruce
Code:
NCT06666712
Conditions
Brain Tumor, Recurrent
Malignant Glioma (WHO Grade III or IV)
IDH1/IDH2 Mutation
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Topotecan
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-14. This information was provided to ClinicalTrials.gov by Jeffrey N. Bruce on 2025-10-06.